 Agile Therapeutics, Inc. NASDAQ:AGRX Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Matthew Riley - Head of Investor Relations Alfred Altomari - Chairman and Chief Executive Officer Amy Welsh - Chief Commercial Officer Jason Butch - Chief Accounting Officer Conference Call Participants Oren Livnat - H.C. Wainwright Nazibur Rahman - Maxim Group LLC Operator Good afternoon, and welcome to the Agile Therapeutics Third Quarter 2022 Financial Results Conference Call. 